Development of human cytomegalovirus-specific T cell immunity during primary infection of pregnant women and its correlation with virus transmission to the fetus.

OBJECTIVE We sought to study the development of human cytomegalovirus (HCMV)-specific T cell-mediated immune responses during primary HCMV infection in pregnancy. METHODS The HCMV-specific lymphoproliferative response (LPR) and intracellular cytokine (interferon [IFN]- gamma and interleukin [IL]-2) production were investigated during the first year after primary infection in 49 pregnant women and 9 nonpregnant control subjects. An HCMV-specific CD4(+) and CD8(+) T cell LPR was detected by the 5,6-carboxyfluorescein diacetate succinimidyl ester dilution method, and a cell-division index was calculated. RESULTS The CD4(+) T cell LPR developed slightly earlier than the CD8(+) T cell LPR. However, CDI values for both T cell subpopulations were lower than those of seropositive control subjects in both pregnant and nonpregnant individuals. During the first month after infection, IFN- gamma -producing CD4(+) and CD8(+) T cells were consistently observed, whereas IL-2-producing T cells were very rarely detected in blood. A correlation between the development of HCMV-specific LPR and virus clearance from blood was observed. A significantly delayed development of the CD4(+) T cell LPR was observed in infected mothers who transmitted virus to the fetus, compared with those who did not. CONCLUSIONS The development of adaptive T cell immunity after primary HCMV infection appears to be a complex and slow process until a memory T cell response develops. The T cell immune response appears to influence vertical HCMV transmission.

[1]  R. Whitley,et al.  Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy , 1981, Infection and immunity.

[2]  M. Furione,et al.  Lymphoproliferative response in primary human cytomegalovirus (HCMV) infection is delayed in HCMV transmitter mothers. , 2006, The Journal of infectious diseases.

[3]  G. Pantaleo,et al.  Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases , 2006, Nature Reviews Immunology.

[4]  E. Remmerswaal,et al.  Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. , 2003, Blood.

[5]  F. Baldanti,et al.  Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. , 2005, The Journal of general virology.

[6]  F. Baldanti,et al.  Improved prenatal diagnosis of congenital human cytomegalovirus infection by a modified nested polymerase chain reaction , 1998, Journal of medical virology.

[7]  P. van Endert,et al.  A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. , 2003, Journal of immunological methods.

[8]  N. Flournoy,et al.  Risk factors for cytomegalovirus infection after human marrow transplantation. , 1986, The Journal of infectious diseases.

[9]  H. Friedman,et al.  Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers. , 1979, The Journal of infectious diseases.

[10]  J. Booth,et al.  An early marker of fetal infection after primary cytomegalovirus infection in pregnancy. , 1986 .

[11]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[12]  W. Britt,et al.  Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. , 1986 .

[13]  P. Griffiths,et al.  Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. , 1999, The Journal of infectious diseases.

[14]  W. Britt,et al.  Antibody response to virus-encoded proteins after cytomegalovirus mononucleosis. , 1987, The Journal of infectious diseases.

[15]  F. Baldanti,et al.  Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[16]  W. Britt,et al.  The outcome of congenital cytomegalovirus infection in relation to maternal antibody status , 1992, The New England journal of medicine.

[17]  S. Riddell,et al.  Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. , 1991, Blood.

[18]  M. Lederman,et al.  In vitro human memory CD8 T cell expansion in response to cytomegalovirus requires CD4+ T cell help. , 2004, Journal of Infectious Diseases.

[19]  G. Gerna,et al.  Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. , 1998, The Journal of infectious diseases.

[20]  A. B. Lyons,et al.  Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. , 2000, Journal of immunological methods.

[21]  D. Lilleri,et al.  Monitoring of Human Cytomegalovirus‐Specific CD4+ and CD8+ T‐Cell Immunity in Patients Receiving Solid Organ Transplantation , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  R. Chaisson,et al.  Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. , 1992, The Journal of infectious diseases.

[23]  N. Flournoy,et al.  Cytomegalovirus infection and specific cell-mediated immunity after marrow transplant. , 1980, The Journal of infectious diseases.

[24]  M. Furione,et al.  Diagnosis and outcome of preconceptional and periconceptional primary human cytomegalovirus infections. , 2002, The Journal of infectious diseases.

[25]  Joshua M. Pearce,et al.  Lymphocyte responses and virus excretion as risk factors for intrauterine infection with cytomegalovirus , 1993, Journal of medical virology.

[26]  L. Kääriäinen,et al.  Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. , 1965, British medical journal.

[27]  D. Lilleri,et al.  Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. , 2006, Blood.

[28]  D. Lilleri,et al.  Simultaneous quantification of human cytomegalovirus (HCMV)‐specific CD4+ and CD8+ T cells by a novel method using monocyte‐derived HCMV‐infected immature dendritic cells , 2005, European journal of immunology.

[29]  T. Merigan,et al.  Antibody response to human cytomegalovirus glycoproteins gB and gH after natural infection in humans. , 1991, The Journal of infectious diseases.

[30]  T. Monath,et al.  Flow-Cytometric Detection of Vaccinia-Induced Memory Effector CD4+, CD8+, and γδTCR+ T Cells Capable of Antigen-Specific Expansion and Effector Functions , 2005 .

[31]  C. von Bonsdorff,et al.  Further studies on cytomegalovirus mononucleosis in previously healthy individuals. , 2009, Acta medica Scandinavica.

[32]  C. Alford,et al.  Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. , 1982, The New England journal of medicine.

[33]  F. Baldanti,et al.  Declining Levels of Rescued Lymphoproliferative Response to Human Cytomegalovirus (HCMV) in AIDS Patients With or Without HCMV Disease Following Long‐Term HAART , 2001, Journal of acquired immune deficiency syndromes.